Pediatrix Medical Group (MD) Stock Forecast, Price Target & Predictions
MD Stock Forecast
Pediatrix Medical Group stock forecast is as follows: an average price target of $18.17 (represents a 20.01% upside from MD’s last price of $15.14) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
MD Price Target
The average price target for Pediatrix Medical Group (MD) is $18.17 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $8.00. This represents a potential 20.01% upside from MD's last price of $15.14.
MD Analyst Ratings
According to 5 Wall Street analysts, Pediatrix Medical Group's rating consensus is 'Hold'. The analyst rating breakdown for MD stock is 0 'Strong Buy' (0.00%), 2 'Buy' (40.00%), 3 'Hold' (60.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Pediatrix Medical Group Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 07, 2024 | David MacDonald | Truist Financial | $13.00 | $12.13 | 7.17% | -14.13% |
| Sep 26, 2024 | Jack Slevin | Jefferies | $14.00 | $11.26 | 24.33% | -7.53% |
| Aug 15, 2024 | David MacDonald | Truist Financial | $10.00 | $10.16 | -1.57% | -33.95% |
| Jun 07, 2024 | Pito Chickering | Deutsche Bank | $8.00 | $6.89 | 16.11% | -47.16% |
| Dec 05, 2022 | - | Credit Suisse | $27.00 | $16.28 | 65.85% | 78.34% |
| Aug 11, 2022 | - | Credit Suisse | $28.00 | $21.27 | 31.64% | 84.94% |
| May 03, 2022 | - | Credit Suisse | $30.00 | $19.02 | 57.73% | 98.15% |
| May 02, 2022 | - | Mizuho Securities | $23.00 | $19.30 | 19.17% | 51.92% |
| Apr 27, 2022 | - | Leerink Partners | $24.00 | $22.73 | 5.59% | 58.52% |
The latest Pediatrix Medical Group stock forecast, released on Oct 07, 2024 by David MacDonald from Truist Financial, set a price target of $13.00, which represents a 7.17% increase from the stock price at the time of the forecast ($12.13), and a -14.13% decrease from MD last price ($15.14).
Pediatrix Medical Group Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 4 |
| Avg Price Target | $13.00 | $12.33 | $11.25 |
| Last Closing Price | $15.14 | $15.14 | $15.14 |
| Upside/Downside | -14.13% | -18.56% | -25.69% |
In the current month, the average price target of Pediatrix Medical Group stock is $13.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a -14.13% decrease as opposed to Pediatrix Medical Group's last price of $15.14. This month's average price target is up 5.43% compared to last quarter, and up 15.56% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 26, 2024 | Jefferies | - | Buy | Upgrade |
| Aug 15, 2024 | UBS | Hold | Hold | Hold |
| Aug 15, 2024 | Truist Financial | Underperform | Underperform | Hold |
| Jun 07, 2024 | Deutsche Bank | - | Hold | Upgrade |
| May 15, 2024 | Truist Financial | Hold | Hold | Hold |
| May 15, 2024 | Mizuho Securities | Underperform | Underperform | Hold |
| Dec 05, 2022 | Credit Suisse | Outperform | Outperform | Hold |
| Aug 11, 2022 | Credit Suisse | Outperform | Outperform | Hold |
| Apr 27, 2022 | SVB Leerink | Market Perform | Market Perform | Hold |
| Feb 23, 2022 | Credit Suisse | Outperform | Outperform | Hold |
Pediatrix Medical Group's last stock rating was published by Jefferies on Sep 26, 2024. The company Upgrade its MD rating from "null" to "Buy".
Pediatrix Medical Group Financial Forecast
Pediatrix Medical Group Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $506.61M | $500.58M | $491.01M | $513.84M | $489.92M | $486.03M | $482.23M | $498.53M | $492.95M | $472.96M | $446.75M | $416.63M | $460.63M | $509.20M | $845.92M | $905.38M | $888.67M |
| Avg Forecast | $481.38M | $488.58M | $482.53M | $473.24M | $489.46M | $499.61M | $486.33M | $471.44M | $482.66M | $498.87M | $505.49M | $497.92M | $523.34M | $507.59M | $495.88M | $490.75M | $501.97M | $511.75M | $491.51M | $474.21M | $483.85M | $480.30M | $453.17M | $426.78M | $458.34M | $573.29M | $555.89M | $852.44M | $901.20M | $876.25M |
| High Forecast | $504.97M | $512.52M | $506.17M | $496.43M | $513.45M | $524.09M | $510.16M | $498.06M | $502.74M | $515.17M | $505.49M | $498.50M | $530.43M | $512.44M | $520.18M | $514.80M | $526.57M | $511.75M | $491.51M | $474.21M | $483.85M | $480.30M | $453.17M | $426.78M | $458.34M | $573.29M | $555.89M | $852.44M | $901.20M | $876.25M |
| Low Forecast | $438.03M | $444.57M | $439.07M | $430.62M | $445.38M | $454.61M | $442.53M | $421.47M | $446.81M | $465.32M | $505.49M | $497.34M | $519.40M | $499.05M | $451.22M | $446.55M | $456.76M | $511.75M | $491.51M | $474.21M | $483.85M | $480.30M | $453.17M | $426.78M | $458.34M | $573.29M | $555.89M | $852.44M | $901.20M | $876.25M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 7 | 3 | 3 | 6 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.00% | 1.02% | 0.96% | 0.99% | 1.02% | 1.03% | 1.03% | 1.04% | 1.05% | 0.91% | 0.80% | 0.92% | 0.99% | 1.00% | 1.01% |
Pediatrix Medical Group's average Quarter revenue forecast for Dec 23 based on 6 analysts is $523.34M, with a low forecast of $519.40M, and a high forecast of $530.43M. MD's average Quarter revenue forecast represents a 3.30% increase compared to the company's last Quarter revenue of $506.61M (Sep 23).
Pediatrix Medical Group EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 7 | 3 | 3 | 6 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.67M | $15.33M | $39.42M | $65.15M | $57.69M | $64.71M | $49.80M | $85.22M | $68.14M | $67.36M | $38.36M | $-23.43M | $-15.16M | $-630.68M | $29.86M | $64.24M | $-1.33B |
| Avg Forecast | $58.52M | $59.39M | $58.66M | $57.53M | $59.50M | $60.73M | $59.12M | $57.31M | $58.67M | $60.64M | $61.45M | $-8.66M | $63.62M | $61.70M | $60.28M | $-7.87M | $73.16M | $62.21M | $59.75M | $-6.22M | $58.82M | $58.39M | $55.09M | $31.95M | $55.72M | $69.69M | $67.58M | $37.82M | $109.55M | $106.52M |
| High Forecast | $61.39M | $62.30M | $61.53M | $60.35M | $62.42M | $63.71M | $62.02M | $60.55M | $61.11M | $62.63M | $61.45M | $-6.93M | $64.48M | $62.29M | $63.23M | $-6.30M | $87.79M | $62.21M | $59.75M | $-4.98M | $58.82M | $58.39M | $55.09M | $38.34M | $55.72M | $69.69M | $67.58M | $45.38M | $109.55M | $106.52M |
| Low Forecast | $53.25M | $54.04M | $53.37M | $52.35M | $54.14M | $55.26M | $53.79M | $51.23M | $54.31M | $56.57M | $61.45M | $-10.39M | $63.14M | $60.67M | $54.85M | $-9.45M | $58.53M | $62.21M | $59.75M | $-7.47M | $58.82M | $58.39M | $55.09M | $25.56M | $55.72M | $69.69M | $67.58M | $30.25M | $109.55M | $106.52M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.48% | 0.25% | -5.01% | 0.89% | 0.93% | 1.08% | -8.00% | 1.45% | 1.17% | 1.22% | 1.20% | -0.42% | -0.22% | -9.33% | 0.79% | 0.59% | -12.51% |
6 analysts predict MD's average Quarter EBITDA for Dec 23 to be $63.62M, with a high of $64.48M and a low of $63.14M. This is 114.43% upper than Pediatrix Medical Group's previous annual EBITDA (Sep 23) of $29.67M.
Pediatrix Medical Group Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 7 | 3 | 3 | 6 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $40.27M | $28.28M | $14.21M | $29.66M | $30.73M | $27.14M | $-20.95M | $40.28M | $30.80M | $35.01M | $17.64M | $-64.30M | $-41.04M | $-672.44M | $-18.71M | $9.33M | $-1.26B |
| Avg Forecast | $33.13M | $32.74M | $34.26M | $24.60M | $32.85M | $32.20M | $32.77M | $22.13M | $30.29M | $31.07M | $26.44M | $-22.93M | $27.47M | $36.77M | $33.99M | $-20.85M | $40.79M | $45.31M | $39.36M | $-16.48M | $36.34M | $34.57M | $26.87M | $14.69M | $29.74M | $30.72M | $6.54M | $-23.70M | $75.67M | $75.67M |
| High Forecast | $35.24M | $34.82M | $36.44M | $26.17M | $34.95M | $34.25M | $34.86M | $25.02M | $31.92M | $32.75M | $26.45M | $-18.35M | $31.76M | $39.33M | $36.15M | $-16.68M | $48.95M | $45.31M | $39.36M | $-13.18M | $36.34M | $34.57M | $26.87M | $17.63M | $29.74M | $30.72M | $6.54M | $-18.96M | $75.67M | $75.67M |
| Low Forecast | $29.25M | $28.90M | $30.24M | $21.72M | $29.01M | $28.43M | $28.94M | $20.20M | $27.83M | $28.55M | $26.43M | $-27.52M | $24.03M | $35.91M | $30.01M | $-25.02M | $32.64M | $45.31M | $39.36M | $-19.78M | $36.34M | $34.57M | $26.87M | $11.75M | $29.74M | $30.72M | $6.54M | $-28.44M | $75.67M | $75.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 0.83% | -0.68% | 0.73% | 0.68% | 0.69% | 1.27% | 1.11% | 0.89% | 1.30% | 1.20% | -2.16% | -1.34% | -102.76% | 0.79% | 0.12% | -16.60% |
Pediatrix Medical Group's average Quarter net income forecast for Dec 23 is $27.47M, with a range of $24.03M to $31.76M. MD's average Quarter net income forecast represents a -31.79% decrease compared to the company's last Quarter net income of $40.27M (Sep 23).
Pediatrix Medical Group SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 7 | 3 | 3 | 6 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $57.41M | $58.01M | $59.06M | $51.06M | $57.89M | $61.16M | $61.29M | $58.98M | $66.89M | $70.97M | $66.52M | $54.67M | $66.35M | $77.67M | $105.23M | $96.93M | $102.36M |
| Avg Forecast | $60.46M | $61.36M | $60.60M | $59.43M | $61.47M | $62.75M | $61.08M | $59.21M | $60.62M | $62.65M | $63.48M | $66.33M | $65.73M | $63.75M | $62.28M | $60.30M | $50.64M | $64.27M | $61.73M | $47.67M | $60.77M | $60.32M | $56.91M | $55.39M | $57.56M | $72.00M | $69.81M | $133.30M | $113.18M | $110.05M |
| High Forecast | $63.42M | $64.37M | $63.57M | $62.35M | $64.48M | $65.82M | $64.07M | $62.55M | $63.14M | $64.70M | $63.48M | $79.60M | $66.62M | $64.36M | $65.33M | $72.36M | $60.76M | $64.27M | $61.73M | $57.20M | $60.77M | $60.32M | $56.91M | $66.47M | $57.56M | $72.00M | $69.81M | $159.96M | $113.18M | $110.05M |
| Low Forecast | $55.01M | $55.83M | $55.14M | $54.08M | $55.94M | $57.09M | $55.58M | $52.93M | $56.11M | $58.44M | $63.48M | $53.06M | $65.23M | $62.68M | $56.67M | $48.24M | $40.51M | $64.27M | $61.73M | $38.13M | $60.77M | $60.32M | $56.91M | $44.31M | $57.56M | $72.00M | $69.81M | $106.64M | $113.18M | $110.05M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.93% | 0.98% | 1.01% | 0.90% | 0.99% | 1.29% | 0.97% | 1.11% | 1.25% | 1.20% | 0.95% | 0.92% | 1.11% | 0.79% | 0.86% | 0.93% |
Pediatrix Medical Group's average Quarter SG&A projection for Dec 23 is $65.73M, based on 6 Wall Street analysts, with a range of $65.23M to $66.62M. The forecast indicates a 14.50% rise compared to MD last annual SG&A of $57.41M (Sep 23).
Pediatrix Medical Group EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 7 | 3 | 3 | 6 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.49 | $0.34 | $0.17 | $0.36 | $0.37 | $0.32 | $-0.25 | $0.47 | $0.36 | $0.41 | $0.21 | $-0.75 | $-0.49 | $-8.05 | $-0.23 | $0.11 | $-15.24 |
| Avg Forecast | $0.39 | $0.39 | $0.41 | $0.29 | $0.39 | $0.38 | $0.39 | $0.26 | $0.36 | $0.37 | $0.31 | $0.18 | $0.32 | $0.43 | $0.40 | $0.23 | $0.48 | $0.54 | $0.47 | $0.27 | $0.44 | $0.41 | $0.32 | $0.13 | $0.36 | $0.37 | $0.08 | $0.55 | $0.91 | $0.91 |
| High Forecast | $0.42 | $0.41 | $0.43 | $0.31 | $0.41 | $0.41 | $0.41 | $0.30 | $0.38 | $0.39 | $0.31 | $0.19 | $0.38 | $0.47 | $0.43 | $0.24 | $0.51 | $0.54 | $0.47 | $0.27 | $0.44 | $0.41 | $0.32 | $0.13 | $0.36 | $0.37 | $0.08 | $0.55 | $0.91 | $0.91 |
| Low Forecast | $0.35 | $0.34 | $0.36 | $0.26 | $0.34 | $0.34 | $0.34 | $0.24 | $0.33 | $0.34 | $0.31 | $0.18 | $0.28 | $0.42 | $0.36 | $0.20 | $0.43 | $0.54 | $0.47 | $0.27 | $0.44 | $0.41 | $0.32 | $0.13 | $0.36 | $0.37 | $0.08 | $0.55 | $0.91 | $0.91 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 0.85% | 0.74% | 0.74% | 0.68% | 0.68% | -0.92% | 1.08% | 0.87% | 1.27% | 1.64% | -2.11% | -1.33% | -102.51% | -0.42% | 0.12% | -16.78% |
According to 6 Wall Street analysts, Pediatrix Medical Group's projected average Quarter EPS for Dec 23 is $0.32, with a low estimate of $0.28 and a high estimate of $0.38. This represents a -33.68% decrease compared to MD previous annual EPS of $0.49 (Sep 23).
Pediatrix Medical Group Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company | $42.33 | $82.33 | 94.50% | Buy |
| MD | Pediatrix Medical Group | $15.14 | $18.17 | 20.01% | Hold |
| PBH | Prestige Consumer Healthcare | $73.79 | $82.00 | 11.13% | Buy |
| SEM | Select Medical | $36.51 | $40.00 | 9.56% | Buy |
| UHS | Universal Health Services | $208.83 | $208.47 | -0.17% | Hold |
MD Forecast FAQ
Is Pediatrix Medical Group a good buy?
No, according to 5 Wall Street analysts, Pediatrix Medical Group (MD) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 40.00% of MD's total ratings.
What is MD's price target?
Pediatrix Medical Group (MD) average price target is $18.17 with a range of $8 to $27, implying a 20.01% from its last price of $15.14. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Pediatrix Medical Group stock go up soon?
According to Wall Street analysts' prediction for MD stock, the company can go up by 20.01% (from the last price of $15.14 to the average price target of $18.17), up by 78.34% based on the highest stock price target, and down by -47.16% based on the lowest stock price target.
Can Pediatrix Medical Group stock reach $20?
MD's highest twelve months analyst stock price target of $27 supports the claim that Pediatrix Medical Group can reach $20 in the near future.
What is Pediatrix Medical Group's current price target trend?
1 Wall Street analyst forecast a $13 price target for Pediatrix Medical Group (MD) this month, down -14.13% from its last price of $15.14. Compared to the last 3 and 12 months, the average price target decreased by -18.56% and decreased by -25.69%, respectively.
What are Pediatrix Medical Group's analysts' financial forecasts?
Pediatrix Medical Group's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.95B (high $2.05B, low $1.76B), average EBITDA is $236.66M (high $248.69M, low $214.43M), average net income is $119.96M (high $129.08M, low $106.58M), average SG&A $244.5M (high $256.93M, low $221.54M), and average EPS is $1.42 (high $1.53, low $1.26). MD's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.93B (high $2.02B, low $1.75B), average EBITDA is $234.1M (high $245.57M, low $213.01M), average net income is $124.72M (high $132.67M, low $110.12M), average SG&A $241.85M (high $253.71M, low $220.07M), and average EPS is $1.48 (high $1.57, low $1.3).
Did the MD's actual financial results beat the analysts' financial forecasts?
Based on Pediatrix Medical Group's last annual report (Dec 2022), the company's revenue was $1.97B, which missed the average analysts forecast of $1.98B by -0.38%. Apple's EBITDA was $237.36M, beating the average prediction of $188.9M by 25.65%. The company's net income was $66.34M, missing the average estimation of $108.98M by -39.13%. Apple's SG&A was $231.4M, beating the average forecast of $224.31M by 3.16%. Lastly, the company's EPS was $0.79, missing the average prediction of $1.77 by -55.42%. In terms of the last quarterly report (Sep 2023), Pediatrix Medical Group's revenue was $506.61M, missing the average analysts' forecast of $507.59M by -0.19%. The company's EBITDA was $29.67M, missing the average prediction of $61.7M by -51.92%. Pediatrix Medical Group's net income was $40.27M, beating the average estimation of $36.77M by 9.53%. The company's SG&A was $57.41M, missing the average forecast of $63.75M by -9.95%. Lastly, the company's EPS was $0.49, beating the average prediction of $0.435 by 12.64%